ICOSAVAX, INC. Operating Cash Flow
ICOSAVAX, INC. reported Operating Cash Flow of -$59.84 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2023-11-14
- ICOSAVAX, INC. net cash provided by (used in) operating activities for the quarter ending 2023-09-30 was -$18.97M.
- ICOSAVAX, INC. net cash provided by (used in) operating activities for the quarter ending 2023-06-30 was -$19.22M.
- ICOSAVAX, INC. net cash provided by (used in) operating activities for the quarter ending 2023-03-31 was -$21.65M.
- ICOSAVAX, INC. net cash provided by (used in) operating activities for the quarter ending 2022-12-31 was -$11.63M.
- ICOSAVAX, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$61.67M.
- ICOSAVAX, INC. net cash provided by (used in) operating activities for fiscal 2021 was -$38.54M.
- ICOSAVAX, INC. net cash provided by (used in) operating activities for fiscal 2020 was -$14.21M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|---|
| 2023-09-30 | -$18.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$38.19M derived: sum of 2 quarters · filed 2023-11-14 | -$59.84M 10-Q · filed 2023-11-14 | -$71.48M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2023-06-30 | -$19.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$40.87M 10-Q · filed 2023-08-14 | -$52.50M derived: sum of 3 quarters · filed 2023-08-14 | -$69.88M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2023-03-31 | -$21.65M 10-Q · filed 2023-05-10 | -$33.28M derived: sum of 2 quarters · filed 2023-05-10 | -$50.66M derived: sum of 3 quarters · filed 2023-11-14 | -$65.86M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-12-31 | -$11.63M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$29.01M derived: sum of 2 quarters · filed 2023-11-14 | -$44.22M derived: sum of 3 quarters · filed 2023-11-14 | -$61.67M 10-K · filed 2023-03-30 | ||
| 2022-09-30 | -$17.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$32.58M derived: sum of 2 quarters · filed 2023-11-14 | -$50.04M 10-Q · filed 2023-11-14 | -$52.67M 10-Q · filed 2022-11-14 | -$63.08M derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | -$15.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$32.66M 10-Q · filed 2023-08-14 | -$35.29M 10-Q · filed 2022-08-15 | -$45.70M derived: sum of 3 quarters · filed 2023-08-14 | -$55.03M derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | -$17.46M 10-Q · filed 2023-05-10 | -$30.50M derived: sum of 2 quarters · filed 2023-05-10 | -$39.82M derived: sum of 3 quarters · filed 2023-05-10 | -$51.82M derived: sum of 4 quarters · filed 2023-05-10 | ||
| 2021-12-31 | -$13.04M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$22.36M derived: sum of 2 quarters · filed 2023-03-30 | -$34.36M derived: sum of 3 quarters · filed 2023-03-30 | -$38.54M 10-K · filed 2023-03-30 | ||
| 2021-09-30 | -$9.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$21.32M derived: sum of 2 quarters · filed 2022-11-14 | -$25.50M 10-Q · filed 2022-11-14 | -$29.19M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | -$12.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$16.18M 10-Q · filed 2022-08-15 | -$19.87M derived: sum of 3 quarters · filed 2022-08-15 | -$22.30M derived: sum of 4 quarters · filed 2022-08-15 | ||
| 2021-03-31 | -$4.18M 10-Q · filed 2022-05-16 | -$7.87M derived: sum of 2 quarters · filed 2022-05-16 | -$10.31M derived: sum of 3 quarters · filed 2022-05-16 | |||
| 2020-12-31 | -$3.69M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$6.13M derived: sum of 2 quarters · filed 2022-03-30 | -$14.21M 10-K · filed 2022-03-30 | |||
| 2020-09-30 | -$2.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$10.52M 10-Q · filed 2021-11-15 | ||||
| 2020-06-30 | -$8.08M 10-Q · filed 2021-09-13 |